| 9/8/2021 |
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination | Financial Buzz |
financialbuzz.com |
CA Healthcare Acquisition Corp. (NASDAQ: CAHC) (“CA Healthcare”), a publicly traded special purpose acquisition company, and LumiraDx Limited (“LumiraDx”), a next-generation point of care diagnostics testing company, announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective LumiraDx’s registration statement on Form F-4 (File No. 333-257745) relating to the previously announced merger of CA Healthcare and LumiraDx. On September 3, 2021 ... |
| 9/7/2021 |
Infectious Disease Point of Care Diagnostics Market 2021 Size & Share | Market worth USD 3371.1 million with 17.4% CAGR by 2027 |
midlandweekly.com |
Press Release] Infectious Disease Point of Care Diagnostics Market 2021 Size & Share Market worth USD 3371.1 million with 17.4% CAGR by 2027 The global “infectious disease point of care diagnostics market” size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth. According to a report published by Fortune Business ... |
| 9/7/2021 |
Infectious Disease Point of Care Diagnostics Market 2021 Size & Share | Market worth USD 3371.1 million with 17.4% CAGR by 2027 |
elmiradaily.com |
The global “infectious disease point of care diagnostics market” size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination ... |
| 9/7/2021 |
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination |
Business Wire |
BOSTON--(BUSINESS WIRE)--Sep 7, 2021-- CA Healthcare Acquisition Corp. (NASDAQ: CAHC) (“CA Healthcare”), a publicly traded special purpose acquisition company, and LumiraDx Limited (“LumiraDx”), a next-generation point of care diagnostics testing company, announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective LumiraDx’s registration statement on Form F-4 (File No. 333-257745) relating to the previously announced merger of CA Healthcare ... |
| 9/7/2021 |
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination |
tmcnet.com |
... and September 28, 2021 Special Meeting to Approve Business Combination CA ( News - Alert ) Healthcare Acquisition Corp. (NASDAQ: CAHC) ("CA Healthcare"), a publicly traded special purpose acquisition company, and LumiraDx Limited ("LumiraDx"), a next-generation point of care diagnostics testing company, announced that the U.S. Securities and Exchange Commission (the "SEC ( http://www.tmcnet.com/tmcnet/snapshots/snapshots.aspx?Company=SEC - http://www.tmcnet.com/enews/subs.aspx?k1=%22SEC%22&k2=+%22SEC+Industrial+Battery%22 )") has ... |
| 9/3/2021 |
LumiraDx Launches Rapid Onsite COVID-19 Surveillance Test |
clpmag.com |
LumiraDx, a next-generation point of care diagnostics testing company, announced the U.S. launch of its COVID-19 Surveillance Test, for environments such as schools and workplaces. The LumiraDx SARS-CoV-2 Ag Surveillance Test allows simultaneous testing of up to five samples on a small, portable instrument with cost per sample as low as $4. With digital results in less than 12 minutes from sample application and a comprehensive ... |
| 9/3/2021 |
Molecular Point of Care Diagnostics Market is Projected to Expand at a Steady CAGR over the Forecast by 2027 |
themarketpublicist.com |
Selbyville, Delaware. Molecular Point of Care Diagnostics Market report provides key statistics on the market status of the Molecular Point of Care Diagnostics Industry and is a valuable source of guidance and direction for companies and individuals interested in the Molecular Point of Care Diagnostics Market. Molecular Point of Care Diagnostics Market Report covers the companies’ data, including Growth potential analysis, Executive Summary, Data sources, Industry segmentation, Porter’s ... |
| 9/2/2021 |
LumiraDx Announces US Launch of its Rapid Onsite COVID-19 Surveillance Test |
PR Newswire |
LONDON , Sept. 2, 2021 /PRNewswire/ -- Today, LumiraDx, a next-generation point of care diagnostics testing company, announced the US launch of its COVID-19 Surveillance Test, for environments such as schools and workplaces. The LumiraDx SARS-CoV-2 Ag Surveillance Test allows simultaneous testing of up to five samples on a small, portable instrument with cost per sample as low as $4 . With digital results in less than 12 minutes ... |
| 8/30/2021 |
Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Prescription Mode, and End User, and Geography |
Globe Newswire |
... hospitalizations in the US suffers from HAI at any given time. Such increase in prevalence of infectious diseases is expected to create a demand for point of care test kits across the world. The point of care diagnostics market is witnessing substantial growth amid the COVID-19 pandemic.Certain factors such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a prominent role in the ... |
| 8/30/2021 |
Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Prescription Mode, and End User, and Geography |
Yahoo News |
The point of care diagnostics market was valued at US$ 36,000. 4 million in 2021 and is projected to reach US$ 82,958. 3 million by 2028; it is expected to grow at a CAGR of 12. 7% from 2021 to 2028. The market growth is primarily attributed to increase in prevalence of infectious diseases, product developments and launches, and rise in number of CLIA-waived POC tests.New York, Aug ... |
| 8/27/2021 |
Point-of-care Diagnostics Market Size to Accelerate at a Rapid CAGR of 6.9% from 2016 to 2024 |
Wordpress.com |
The global point of care diagnostics market is growing at a healthy CAGR. It is expected to receive a boost during the forecast period, taking the market evaluation US$11.7 bn by 2024 end.The market witnesses increasing advancements and investments in products, driven by a robust competition. The key players in the point of care diagnostics market are Alere Inc, Becton Dickinson and Co., Abbott Inc., F. Hoffmann-La ... |
| 8/26/2021 |
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market |
marketsandmarketsblog.com |
... growing demand for the early diagnosis of infectious diseases of driving the growth of the point-of-care diagnostics market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185COVID-19 Impact on the global point of care diagnostics market The COVID-19 pandemic has significantly affected the point of care diagnostics market. The outbreak of COVID-19 has expedited the global demand for diagnostic kits to rapidly detect thedisease. However ... |
| 8/26/2021 |
ABBOTT IS A worldwide Chief IN Immediate Position OF Treatment DIAGNOSTICS |
bookmarkspring.com |
ABBOTT IS A world Chief IN RAPID POINT OF CARE DIAGNOSTICS WITH A selection of Speedy MOLECULAR, ANTIGEN AND ANTIBODY COVID-19 Exams THAT DELIVER Outcomes Inside of 20 MINUTES. Determined by urgent demand from companies, Abbott is working with third party healthcare suppliers to supply A variety of thorough COVID http://brylinski.cct.lsu.edu/sites/all/modules/pubdlcnt/pubdlcnt.php?file=https://getlisting.org ... |
| 8/25/2021 |
Point of Care Diagnostics Market Comprehensive Study by Key Players: World Health Organization, Public Health Agency of Canada |
picayunecurrent.com |
The Global Point of Care Diagnostics Market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018. The market is estimated to grow with a CAGR of 11.8% from 2019-2027. Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, Canadian Diabetes Association, National Healthcare Safety Network (NHSN), International Diabetes ... |
| 8/23/2021 |
LumiraDx and CA Healthcare Acquisition revise merger agreement |
medicaldevice-network.com |
... raised by CAHC in its initial public offering. Assuming no redemptions of current public stakeholders of CAHC, the merged company is expected to receive this sum in cash held in trust. LumiraDx is a point of care diagnostics testing company with ten new tests awaiting approvals in the next two years on its platform, including Troponin, Flu/Covid and tuberculosis tests. The company’s growth in implementing its platform, extending ... |
| 8/23/2021 |
Point of Care (PoC) Diagnostics Market Size & Landscape Outlook, Revenue Growth Analysis to 2028 by Reports And Data |
heraldkeeper.com |
... is attributed to rapidly growing geriatric population, increasing prevalence of target diseases worldwide, rising burden of infectious diseases such as COVID-19, and technological advancements in point of care diagnostic devices. Extensive use of point of care diagnostics for home healthcare, surging demand for rapid and accurate diagnostic results, increasing cases of COVID-19 worldwide, and rising volumes of molecular and antibody point of care diagnostic tests are the other ... |
| 8/23/2021 |
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market |
express-press-release.net |
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market Market Overview: The global point-of-care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4% during the forecast period. Factors such as the growing increase in the prevalence of infectious diseases globally, extensive focius on research and development activities ... |
| 8/23/2021 |
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market |
PRSync |
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market [Markets and markets] Submitted by [swapnil] . [point-of-care diagnostics market] size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4% during the forecast period. Factors such as the growing increase in the prevalence of infectious diseases globally, extensive focius on research and ... |
| 8/20/2021 |
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics | Financial Buzz |
financialbuzz.com |
Today, LumiraDx, a next-generation point of care diagnostics testing company, and CA Healthcare Acquisition Corp (Nasdaq: CAHC), a special purpose acquisition company focused on investing in a growth-oriented healthcare company, announced they have revised the valuation of their previously announced transaction based on various considerations, including the recent market environment for publicly traded diagnostic companies, general market declines in COVID-19 testing volumes, and feedback from CA Healthcare ... |
| 8/18/2021 |
Infectious Disease POC Diagnostics Market Size | Is Expected to Reach USD 3.96 Billion by 2028 while Exhibiting an Impressive CAGR of 17.2% |
Yahoo News |
Key Prominent Players Covered in the Infectious Disease Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland) , Thermo Fisher Scientific Inc. (Massachusetts, U.S.) , Abbott Laboratories (Illinois, U.S) , Quest Diagnostics Incorporated (New Jersey, United States) , BD (Franklin Lakes, U.S) , bioMérieux SA (Marcy l'Etoile, France) , Cardinal Health, Inc. (Ohio, U.S) , Mesa Biotech (California, U.S) , Cepheid (California, U.S) , Trinity Biotech (Bray, Ireland) , Quidel Corporation (San Diego ... |